Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Subscribe To Our Newsletter & Stay Updated